Directs the attention to the smart digital healthcare system in this COVID-19 pandemic. Simulates novel investigations and how they will be beneficial in understanding the pandemic. Presents the latest ideas developed for data scientists, doctors, engineers, and economists. Analyses the various issues related to computing, AI apps, big data analytic techniques, and predictive scientific skill gaps. Explains some interesting and diverse types of challenges and data-driven healthcare applications.

Edited by the inventor of PCR and two prominent experts in PCR techniques, this first comprehensive handbook on the Polymerase Chain Reaction has the most up to date methodological protocols from the world's leading laboratories. Included are exciting new techniques and enhanced methods, previously unavailable in book form, that show the novice and experienced PCR user exactly how they can optimize their results. The applications chapters are quite unique, with the foremost researchers providing not only protocols, but explaining why PCR has revolutionized their particular field. Future enhancements of PCR as well as new potential uses are discussed. Readers will learn how PCR has changed the face of diagnostic testing, cancer research, genetics, forensics, plant biology, DNA sequencing, gene therapy, and much more! Nearly forty chapters have been extensively reviewed and checked for accuracy and breadth of subject matter.

Shape your heart to front the hour, but dream not that the hour will lost. Alfred Tennyson Locksley Hall Sixty YeO , After Numerous advances in the life sciences have necessitated the need to develop gentle, quick and economical methods for separation of proteins/enzymes. Affmity-based separations, with their high selectivity, have thus come to be used more frequently. In the beginning, we just had atrmity chromatography. Today we have several strategies that employ atrmity interactions for separa tion and analysis. This book is an attempt to provide a short introduction and illustrative protocols for some important and current affinity-based approaches inthe area ofdownstream processingofenzymes/proteins. Today, people from a variety of disciplines have to purify proteins. It is hoped that this book will provide some quick insight into the various available options and guide even a novice (in the area ofprotein separation) to obtain his/her target protein at the level of purity that he/she desires."

This new volume provides an abundance of information on new biomedical applications being used today. The book covers a wide range of concepts and technologies, discussing such modern technological methods as the Internet of Things, e-pills, biomedical sensors, support vector machines, wireless devices, image and signal processing in e-health, and machine learning. It also includes a discussion on software implementation for the devices used in biomedical applications. The different types of antennas, including antennas using RF energy harvesting for biomedical applications, are covered as well.

This new volume, Natural Polymers for Pharmaceutical Applications, Volume 1: Plant-Derived Polymers, presents some of the latest research on the applications of natural polymers in drug delivery and therapeutics for healthcare benefits. Polymers and their applications from several plants are discussed in depth, including tamarind gum, gum Arabic, natural carbohydrate polymer gum tragacanth, pectin, guar gum and its derivatives, locust bean gum, sterculia gum, okra gum, and others. The use of the polymers derived from plants as potential pharmaceutical excipients is expanding day by day because of their stability in the biological system, drug-releasing capability, drug-targeting abilities, as well as their bioavailability.

Many polymers derived from various marine sources and microorganisms possess some important biological properties such as biocompatibility, biodegradability, and bioadhesivity that make them attractive as pharmaceutical excipients in various pharmaceutical dosage forms. Moreover, these polymers can be modified physically and/or chemically to improve their biomaterial properties. In this volume, Natural Polymers for Pharmaceutical Applications, Volume 2: Marine- and Microbiologically Derived Polymers, looks at how these polymers have been explored and exploited for pharmaceutical uses, such as in tablets, microparticles, nanoparticles, ophthalmic preparations, gels, emulsions, suspensions, etc. Some commonly used marine- and microbiologically derived polymers used as pharmaceutical excipients include alginates, agar-agar, gellan gum, carrageenan; chitosan, xanthan gum, and others. The book focuses on important recent advances from experts around the world on marine-derived polysaccharides and pharmaceutical applications of alginates, agar-agar, gellan gum, carrageenan, chitosan derivatives, xanthan gum.

In recent years, many animal-derived polymers have emerged as an attractive category of naturally derived polymers because of their advantageous physicochemical, chemical, and biological properties. The important biological properties of these natural polymers derived from animals are biocompatibility and biodegradation. These polymers are generally composed of repeated units of amino acids. Moreover, these polymers can be modified physically and/or chemically to improve their biomaterial properties. Natural Polymers for Pharmaceutical Applications, Volume 3: Animal-Derived Polymers looks at how these polymers can be exploited as pharmaceutical excipients in various pharmaceutical dosage forms, like microparticles, nanoparticles, ophthalmic preparations, gels, implants, etc. The commonly used animal-derived polymers used as pharmaceutical excipients are hyaluronic acid (hyaluronan), albumin, collagen, gelatin, chondroitin, etc.

This book critiques the decision-making process in Article 53(a) of the European Patent Convention. To date, such decisions have been taken at high levels of expertise without much public involvement. The book eschews traditional solutions, such as those found within legislative, judicial and patent office realms and instead develops a radical blueprint for how these decisions can be put to the public. By examining wide-scale models of participatory democracy and deliberation, this book fills a significant gap in the literature. It will be invaluable for patent lawyers, academics, practitioners and intellectual property and patent officials.

This book provides a well-focused and comprehensive overview of novel technologies involved in advanced microfluidics based diagnosis via various types of prognostic and diagnostic biomarkers. This authors examine microfluidics based diagnosis in the biomedical field as an upcoming field with extensive applications. It provides a unique approach and comprehensive technology overview for diagnosis management towards early stages of various bioanalytes via cancer diagnostics diabetes, alzheimer disease, toxicity in food products, brain and retinal diseases, cardiovascular diseases, and bacterial infections etc. Thus, this book would encompass a combinatorial approach of medical science, engineering and biomedical technology. The authors provide a well-focused and comprehensive overview of novel technologies involved in advanced microfluidics based diagnosis via various types of prognostic and diagnostic biomarkers. Moreover, this book contains detailed description on the diagnosis of novel techniques. This book would serve as a guide for students, scientists, researchers, and microfluidics based point of care technologies via smart diagnostics and to plan future research in this valuable field.

"Hills is probably the best person I can think of to write this book. He has the deepest background combined with considerable experience in solving problems with food." —R. G. Bryant, University of Virginia.

Food scientists have many excellent tools at their disposal with which to study food at both the micro- and macrostructural levels. But, when it comes to analyzing dynamic structural changes in food during processing and storage, none can compare with magnetic resonance imaging (MRI). Still a very young approach, MRI food imaging has contributed greatly to recent advances in food science, and promises to yield much more valuable information in the years ahead. Written by a leading pioneer in the field, Magnetic Resonance Imaging in Food Science covers the latest in MRI food imaging theory and practice.

Written primarily for food scientists and engineers, the book offers a practical, unified approach to the subject. Material is organized in three main parts corresponding to the distances of scale probed by MRI studies—namely, the macroscopic, microscopic, and macromolecular. Throughout, the emphasis is on ways in which studies of food undergoing processes can be modeled using the equations of heat, mass, and momentum transport, and how those models can be used in process design optimization programs.

Magnetic Resonance Imaging in Food Science provides researchers with the most up-to-date, detailed coverage of:

• Traditional and cutting-edge MRI food imaging techniques and technologies, including STRAFI, gradient-echo imaging, and functional imaging
• Whole plant functional imaging, flow imaging and rheology, and other specialized MRI applications
• The roles of food microstructure and molecular relaxation mechanisms in controlling moisture and heat transport
• Techniques for modeling structural changes during food processing.

Magnetic Resonance Imaging in Food Science is an important working resource for all researchers engaged in the never-ending struggle to produce safer, higher-quality foods more efficiently.

This monograph introduces current genome editing technologies-clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated (Cas) systems, transcription activator-like effector nucleases (TALENs), and zinc-finger nucleases (ZFNs)-and provides an assessment of the risk of misuse of these technologies based on the following parameters: accessibility, ease of misuse, magnitude of potential harm, and imminence of potential misuse. The findings from this assessment are applied to analyze and evaluate the threat posed by the intentional misuse of genome editing technologies to develop biological weapons. Furthermore, the book discusses the implications of misuse for different applications of genome editing, such as making existing pathogens more dangerous, modifying the human microbiome, weaponizing gene drives, engineering super soldiers, and augmenting the general population to confer economic advantages. Technologies that enable genome editing with programmable nucleases-including CRISPR, TALEN, and ZFN-allow for the precise genetic modification of organisms and cultured cells. While these technologies are used for a variety of beneficial applications, intelligence and defense experts have raised concerns that genome editing technologies, especially CRISPR, could be misused to develop new and improved biological weapons. Furthermore, experts worry that the number and type of actors who could potentially misuse genome editing is dramatically increasing given the democratization of biology, which is allowing biology to become more accessible to everyone including nonexperts. The book provides a comprehensive assessment of how feasible it is for users with different levels of knowledge and skill to acquire and then to apply the technologies to develop a biological weapon. It also provides an assessment of governability and a tailored set of recommendations that address security concerns. These recommendations are sensitive to the cost-benefit trade-off of regulating genome editing technologies. The book targets researchers as well as intelligence analysts, defense and security personnel, and policymakers.

MICROBIAL INTERACTIONS AT NANOBIOTECHNOLOGY INTERFACES This book covers a wide range of topics including synthesis of nanomaterials with specific size, shape, and properties, structure-function relationships, tailoring the surface of nanomaterials for improving the properties, interaction of nanomaterials with proteins/microorganism/eukaryotic cells, and applications in different sectors. This book also provides a strong foundation for researchers who are interested to venture into developing functionalized nanomaterials for any biological applications in their research. Practical concepts such as modelling nanomaterials, and simulating the molecular interactions with biomolecules, transcriptomic or genomic approaches, advanced imaging techniques to investigate the functionalization of nanomaterials/interaction of nanomaterials with biomolecules and microorganisms are some of the chapters that offer significant benefits to the researchers.

Animal cell technology aims to understand structures, functions, and behaviors of differentiated animal cells and to ascertain their abilities to be used in industrial and medical purposes. This volume gives readers a complete review of the present state of the art in Japan.

Nanomedicine, a scientific branch of nanotechnology that operates on the same scale as biology, offers the possibility of influencing the healing process from inside of the body by manipulating the matter at cellular or molecular levels. Throughout this book, current healing approaches based on this revolutionary new technology are summarized from a scientific assessment. The aim of the authors is to give, through select examples, a deep insight to nanotechnology status and the great progress that its rigorous application will bring to human health. The authors' commitment is to broaden the vision of health professionals who will eventually be the future users of this knowledge.

The book discusses in a detailed manner various nanomaterials used for biomedical applications, including clinical applications, diagnosis and tissue engineering. After the presentation of an overview of biomedical nanomaterials, including their classification and applications, the first part of the book is devoted to biomedical nanomaterials for therapy applications. For example, polymer micelles, dendrimers, polymer-drug conjugates as well as antibody-drug conjugates are discussed with respect to their cancer drug delivery properties. The next parts discuss biomedical nanomaterials that are used for imaging, diagnosis and sensors, as well as for tissue engineering. In the final section, the safety of biomedical nanomaterials is elaborated.

Explores how antiviral nanomaterials can be used in developing targeted drug delivery practices and enable pharmaceutical industries to reformulate available drugs on market Covers immunization, imaging, and drug delivery and features various case studies on managing viral diseases Addresses synthesis protocols and recent developments by performing physicochemistry on virion substrate, hybrid viral networks, and multilayered arrays thus enabling R&D experts to study and successfully instigate cutting-edge technologies unique to viruses Discusses current and near future applications of antiviral nanomaterials and their activity in drug delivery systems Describes the role of nanotechnology in prevention, detection, and treatment of COVID-19 Investigates the role of antiviral nanodrugs play in human and animal body systems and in major viral disease types.

Micropropagation of plants is a multibillion dollar industry being prac- ticed in hundreds of small and large nurseries and commercial labora- tories throughout the world. At present, it is the only component of plant biotechnology which has been commercially exploited on such a large scale, especially for the production of ornamentals. Now micro- propagation of trees and medicinal plants has also assumed great im- portance. With recent progress made in the propagation of fruit and forest trees, and the immediate need for afforestation and planting of orchards, propagules and plantlets are required quickly and in large numbers. Taking these points into consideration High-Tech and Micro- propagation I, If, If I, and IV were published in 1991 and 1992. The present two volumes, High-Tech and Micropropagation V and VI, com- prise 51 chapters contributed by international experts from 24 countries. High-Tech and M icropropagation V comprises 24 chapters arranged into the following three sections: I. Vegetables and fruits (garlic, Amaranthus, Brassica oleracea, pepper watermelon, cassava, banana, Myrtus communis, passionfruit, Poly- mnia sonchifolia, pepino, and spinach) II. Grasses (bamboos, Caustis dioica, Dendrocalamus, Miscanthus x giganteus, sugarcane) III. Trees (Aegle marmelos, Eucalyptus, Fraxinus excelsior, Juglans cinerea, Pinus virginiana, Prosopis, and Ulmus species) High-Tech and Micropropagation VI comprises 27 chapters arranged in two sections: I.

This book reviews the state of the art in the use of organic materals as physical, chemical and biomedical sensors in a variety of application settings. Topics covered include organic semiconductors for chemical and physical sensing; conducting polymers in sensor applications; chemically functionalized organic semiconductors for highly selective sensing; composite organic-inorganic sensors; artificial skin applications; organic thin film transistor strain gauges for biomedical applications; OTFT infrared sensors for touchless human-machine interaction; smart fabric sensors and e-textile technologie; image capture with organic sensors; organic gas sensors and electronic noses; electrolyte gated organic transistors for bio-chemical sensing; ion-selective organic electrochemical transistors; DNA biosensors; metabolic organic sensors; and conductive polymer based sensors for biomedical applications.

The advances in microsystems offer new opportunities and capabilities to develop systems for biomedical applications, such as diagnostics and therapy. There is a need for a comprehensive treatment of microsystems and in particular for an understanding of performance limits associated with the shrinking scale of microsystems. The new edition of Microsystems for Bioelectronics addresses those needs and represents a major revision, expansion and advancement of the previous edition. This book considers physical principles and trends in extremely scaled autonomous microsystems such as integrated intelligent sensor systems, with a focus on energy minimization. It explores the implications of energy minimization on device and system architecture. It further details behavior of electronic components and its implications on system-level scaling and performance limits. In particular, fundamental scaling limits for energy sourcing, sensing, memory, computation and communication subsystems are developed and new applications such as optical, magnetic and mechanical sensors are presented. The new edition of this well-proven book with its unique focus and interdisciplinary approach shows the complexities of the next generation of nanoelectronic microsystems in a simple and illuminating view, and is aimed for a broad audience within the engineering and biomedical community.

The complete guide to investing in the biotech industry

"Clear, never condescending, and with abundant references to biotech firms and their work in progress, The Biotech Investor’s Bible is a book that had to be written. Essential for the investor, fascinating even for armchair students of the industry, it’s a valuable reference, a guide to what is coming, and an irresistible read . . . it will be a definitive reference in the field."––Andrew Allentuck, globetechnology.com

"The Biotech Investor’s Bible outlines sensibly and with balance the opportunities and challenges of an industry that will change our lives. A must read guide for the individual investor."––William A. Haseltine, Ph.D., Chairman, CEO, and Founder, Human Genome Sciences, Inc., Editor-in-chief, E-Biomed: The Journal of Regenerative Medicine

Investors with a practical understanding of biotechnology share a remarkable opportunity: the chance to invest in an industry on the threshold of tremendous growth. With the long-term potential to cure most major diseases and to revolutionize industries as diverse as pharmaceuticals and forestry, petrochemicals and agriculture, the possibilities for biotech––and its investors––are limitless.

The Biotech Investor’s Bible provides you with the strategies and proven techniques to reduce risk and increase returns, including:

• The steps you must know in order to assess the biotech market •
• A comprehensive look at 185 major biotech companies •
• Guidelines to follow when planning your biotech portfolio •
• An overview of the latest biotech therapies and breakthroughs •
• Tips on how to find sound and promising companies in the sector •
• An easy-to-understand introduction to the science and technology in the field •

An integrated approach to provide information about all aspects of cancer biology, diagnosis and therapy. Covers both conventional and emerging tools/ techniques applicable in cancer screening and diagnosis. Covers the mechanisms of conventional and emerging anticancer drugs and therapies. Provides insights about personalized medicine based approach in cancer diagnosis and therapy.

This book is an all-embracing review of biotechnology, biomedical engineering, bioinformatics, pharmacy and medicinal chemistry, and biopharmaceutical technology. Existing theories and the latest findings are discussed. Researchers, engineers, academics, and industry professionals will find this book an invaluable read.

Introduces an approach to ethical decision making based on treating data as clients Compares the ethics of three professions; engineering, medicine and bioengineering Provides five moral theories to choose from for evaluating ethical decisions, and includes a procedure for applying them to moral analysis, and application of the procedure to example cases. Explains the process of developing a medical product under FDA regulation Explores the role of lawyers in product development, including intellectual property protection Examines a range of ethical cases, from the historical Tuskegee autonomy case to the modern CRISPR-Cas9 patent case.

Explores planning for biogas plants as a pre-requisite to develop a functional plant balancing energy production and consumption Gives out detailed provision of the types of substances that are and can be used for biogas production covering animal wastes, municipal and industrial wastes Provides knowledge for aspiring biogas producers as well as decision makers, specifically in the context of Nigeria Covers use of digestrate for anaerobic digestion as a waste treatment method and on the input (feedstock) to the biogas plant Compares carbon dioxide emissions from biogas plants with fossil fuel plants

The intent of this book is to provide a detailed and specific set of guidelines for both aquapreneurs and researchers related to the application of Biofloc Technology in aquaculture. This book discusses key issues related to both adoption and practices for aquaculture businesses, how to monitor and assess quality and quantity of biofloc, and how to manage the microbial composition and sludge reduction risk in the fish and shrimp culture. The book works through the specific application of disease management and feed management tools for aquaculture from the perspective of this technology. Particular attention is paid on comparing the prototypes of floc development and evaluation on its efficacy in aquaculture. Note: T&F does not sell or distribute the hardback in India, Pakistan, Nepal, Bhutan, Bangladesh and Sri Lanka.